mergers and acquisitions
Bayer to acquire Schiff Nutrition
November 4, 2012Sales and Marketing Bayer, mergers and acquisitions
Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …
GSK’s bid for Human Genome Sciences rejected
April 19, 2012Sales and Marketing Benlysta, GSK, Human Genome Sciences, mergers and acquisitions
GlaxoSmithKline has launched a takeover bid for Human Genome Sciences for around $2.5 billion, but has been rejected by the …
Roche abandons Illumina takeover bid
April 19, 2012Sales and Marketing Diagnostics, Illumina, Roche, mergers and acquisitions
Roche has conceded defeat in its bid to buy Illumina, after shareholders of the diagnostics firm blocked the takeover – …
Roche changes raise Novartis takeover question
March 29, 2011Sales and Marketing Novartis, Roche, mergers and acquisitions
Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom. The Roche family …
Sanofi extends Genzyme share deal deadline
December 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions
Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
Celgene completes Abraxis takeover
October 15, 2010Research and Development, Sales and Marketing Abraxane, Abraxis, Celgene, mergers and acquisitions, oncology
Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …
